ArticleFrontiers in microbiology2022
Antimicrobial resistance and genomic characterization of
Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 37 citations in OpenAlex.
- Genomic Epidemiology and Machine Learning-Based Drug Discovery for Antimicrobial Resistant Diarrheagenic Escherichia coli.MicrobiologyOpen · 2026Article
- Prevalence and Differential Plasmid Versus Chromosomal Distribution of Ribosome-Targeting Antibiotic Resistance Genes inAntibiotics (Basel, Switzerland) · 2026Article
- Evolutionary trends and genetic determinants of third-generation cephalosporin resistance inFrontiers in microbiology · 2026Article
- Deep learning from videography as a tool for measuringRoyal Society open science · 2025Article
- Predisposing Factors Associated with Third-Generation Cephalosporin-ResistantAntibiotics (Basel, Switzerland) · 2025Article
- Antimicrobial Resistance Genotypes and Mobile Genetic Elements of Poultry-DerivedPathogens (Basel, Switzerland) · 2025Article
- Genomic features of three major diarrhoeagenicMicrobial genomics · 2025Article
- Whole-genome analysis of fiveMicrobiology spectrum · 2025Article
- Fecal carriage and molecular characterization of carbapenem-resistantFrontiers in microbiology · 2025Article
- Drug resistance and pathogenicity characteristics ofFrontiers in veterinary science · 2025Article
- Tracing the transmission of carbapenem-resistant Enterobacterales at the patient: ward environmental nexus.Annals of clinical microbiology and antimicrobials · 2024Article
- Molecular Characterization of Multidrug-ResistantVeterinary sciences · 2024Article
- Pathogenomes of Shiga Toxin Positive and NegativeMicroorganisms · 2024Article
- Pathogenomes and virulence profiles of representative big six non-O157 serogroup Shiga toxin-producingFrontiers in microbiology · 2024Article
- Characteristics, Whole-Genome Sequencing and Pathogenicity Analysis ofMicroorganisms · 2023Article
- Identification, Typing, and Drug Resistance Analysis ofAnimals : an open access journal from MDPI · 2023Article
- Implementation of WGS analysis of ESBL-producing Escherichia coli within EU AMR monitoring in livestock and meat.The Journal of antimicrobial chemotherapy · 2023Article
- Detection of Antibiotic Resistance in Feline-Origin ESBLInternational journal of molecular sciences · 2023Article
- Comparison of Epidemiological Characteristics Between ESBL and Non-ESBL Isolates of Clinically IsolatedInfection and drug resistance · 2023Article
- Genomic Determinants of Pathogenicity and Antimicrobial Resistance of NosocomialInfection and drug resistance · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
14 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.